Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
15.17%
End price
05.11.21
€29.29
Summary
This prediction ended on 05.11.21 with a price of €29.29. The BUY prediction by stratec finished with a performance of 15.17%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | -0.820% | -0.820% | -60.968% | -60.968% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% | 50.231% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% | 101.082% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% | 69.384% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% | 70.971% |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten